Evidence map›Paper›PMID 42909218›Full record

ArticleCureus2026

A Case of Punctate Inner Choroidopathy in the Fellow Eye Followed by the Development of Solitary Punctate Chorioretinitis With Choroidal Neovascularization.

Atsuki Fukushima, Tomoki Shirakami, Keigo Murata, Hitoshi Tabuchi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Atsuki FukushimaOphthalmology, Tsukazaki Hospital, Himeji, JPN.
Tomoki ShirakamiOphthalmology, Tsukazaki Hospital, Himeji, JPN.
Keigo MurataOphthalmology, Tsukazaki Hospital, Himeji, JPN.
Hitoshi TabuchiOphthalmology, Hiroshima University, Hiroshima, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the clinical course of a patient who developed punctate inner choroidopathy (PIC) followed by solitary punctate chorioretinitis (SPC), and subsequently developed choroidal neovascularization (CNV) after a prolonged period. We also discuss the importance of examination and diagnosis using multimodal imaging, as well as the significance of follow-up. A 35-year-old woman with high myopia presented with a one-week history of central visual disturbance in her left eye. Examination revealed multiple white dots in the left macula, but none in the right eye. Based on multimodal imaging findings typically for PIC, she was diagnosed with PIC and placed under observation. Three years after the initial visit, a solitary white dot appeared superonasal to the fovea in the right macula, leading to a diagnosis of SPC based on multimodal imaging. Although findings in both eyes gradually worsened thereafter, no CNV was observed. Thirteen and a half years after the onset of right eye findings, she presented with a complaint of rapid vision loss, and CNV was detected in the right eye; no CNV was observed in the left eye. Based on these results, the CNV was attributed to the SPC in the right eye, and treatment involving intravitreal anti-vascular endothelial growth factor agent injections and sub-Tenon's injections of triamcinolone acetonide was initiated. In this case, CNV developed 13 years after the confirmation of SPC. Thus, for cases of unilateral PIC, it is essential to bear in mind the potential for developing SPC and the subsequent risk of CNV arising from SPC over the long term, and to conduct regular evaluations using multimodal imaging.

Indexed as

choroidal neovascularizationmultimodal imagingpunctate inner choroidopathysolitary punctate chorioretinitiswhite dot syndrome

Identifiers

PMID42909218
PMCPMC13684343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.